Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share & Trends Analysis Report By Service (Laboratory, Custom), By Raw Material (Formulation Excipients, API), By Region, And Segment Forecasts, 2024

Description

Biopharmaceuticals Manufacturing Consumables Testing Market Growth & Trends:

The global biopharmaceuticals manufacturing consumables testing market size is expected to reach USD 1.27 billion by 2030, registering a CAGR of 12.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Biopharmaceuticals Manufacturing Consumables Testing Market Report Highlights:

Based on service, compendial and multi-compendial testing held the largest share owing to demand from various manufacturers for raw materials that are compliant to regulatory standards
Testing services for Active Pharmaceutical Ingredients (APIs) accounted for the largest revenue share owing to the presence of a wide range of services in this segment
Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2023. Rising competitive rivalry amongst market participants is also attributive for the large share of this region
Asia Pacific is expected to emerge as the fastest-growing regional market, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations

Product Code: GVR-2-68038-398-0

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Biopharmaceuticals Manufacturing Consumables Testing Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Movement Analysis, USD Million, 2023 & 2030
4.3. Laboratory Testing
- 4.3.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
4.4. Custom Testing / Customer Proprietary Testing
- 4.4.1. Custom Testing / Customer Proprietary Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
4.5. Compendial & Multi Compendial Laboratory Testing
- 4.5.1. Compendial & Multi Compendial Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Movement Analysis, USD Million, 2023 & 2030
5.3. Formulation Excipients
- 5.3.1. Formulation Excipients Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
5.4. Active Pharmaceutical Ingredients (API)
- 5.4.1. Active Pharmaceutical Ingredients (API) Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
5.5. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
- 5.5.1. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis

6.1. Biopharmaceuticals Manufacturing Consumables Testing Market Share, By Region, 2023 & 2030, USD Million
6.2. North America
- 6.2.1. North America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.2. UK
  - 6.3.2.1. UK Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.5. Italy
  - 6.3.5.1. Italy Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.6. Spain
  - 6.3.6.1. Spain Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.8. Sweden
  - 6.3.8.1. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.3.9. Norway
  - 6.3.9.1. Norway Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.4.2. China
  - 6.4.2.1. China Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.4.3. Japan
  - 6.4.3.1. Japan Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.4.5. South Korea
  - 6.4.5.1. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.4.6. Australia
  - 6.4.6.1. Australia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.6.2. Saudi Arabia
  - 6.6.2.1. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.6.3. UAE
  - 6.6.3.1. UAE Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.6.4. South Africa
  - 6.6.4.1. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. Alcami Corporation
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Merck KGaA
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Eurofins Scientific
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Agilent Technologies, Inc.
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Charles River Laboratories.
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Catalent, Inc
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Element Materials Technology (Avomeen Analytical Services)
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Pace Analytical Services, LLC
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Nelson Laboratories, LLC (Gibraltar Laboratories)
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives

Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share & Trends Analysis Report By Service (Laboratory, Custom), By Raw Material (Formulation Excipients, API), By Region, And Segment Forecasts, 2024 - 2030